
The XPRIZE Foundation, under the leadership of founder and Executive Chairman Peter H. Diamandis, MD, continues its ambitious $101 million XPRIZE Healthspan competition, driving innovation to revolutionize healthy human aging. This global initiative challenges teams to develop therapies capable of restoring muscle, cognitive, and immune function by a minimum of 10 years, with an ultimate goal of 20 years. The competition aims to make healthy aging accessible to everyone, fundamentally transforming the quality of life in later years.
The XPRIZE Healthspan, launched in 2023 with a planned conclusion in 2030, seeks proactive and accessible therapeutic solutions that reduce the risk of chronic age-related diseases. According to the XPRIZE Foundation, the current healthcare system predominantly treats symptoms after they manifest, a reactive approach that extends life but often neglects the proactive improvement of health. This competition incentivizes a paradigm shift towards preventative and restorative health interventions.
Dr. Diamandis, a renowned futurist and advocate for exponential technologies, has consistently championed initiatives that address humanity's grand challenges. His vision for the XPRIZE Healthspan aligns with his broader goal of creating a future of abundance, leveraging scientific breakthroughs to extend human potential. The competition encourages a diverse range of innovators, from academic researchers to startups, to contribute to this critical field.
The winning team of the $101 million prize must demonstrate a therapeutic treatment that restores the specified functions within a one-year timeframe for individuals aged 50-80. This rigorous requirement underscores the competition's commitment to tangible, impactful results. The ongoing progress of the XPRIZE Healthspan signifies a major step toward a future where longer, healthier lives are a widespread reality, offering more time for personal fulfillment and societal contributions.